Literature DB >> 22560849

A new model to analyze metaphyseal bone healing in mice.

Tina Histing1, Moritz Klein, Andrea Stieger, David Stenger, Roland Steck, Romano Matthys, Joerg H Holstein, Patric Garcia, Tim Pohlemann, Michael D Menger.   

Abstract

BACKGROUND: Despite the increasing clinical problems with metaphyseal fractures, most experimental studies investigate the healing of diaphyseal fractures. Although the mouse would be the preferable species to study the molecular and genetic aspects of metaphyseal fracture healing, a murine model does not exist yet. Using a special locking plate system, we herein introduce a new model, which allows the analysis of metaphyseal bone healing in mice.
METHODS: In 24 CD-1 mice the distal metaphysis of the femur was osteotomized. After stabilization with the locking plate, bone repair was analyzed radiologically, biomechanically, and histologically after 2 (n=12) and 5 wk (n=12). Additionally, the stiffness of the bone-implant construct was tested biomechanically ex vivo.
RESULTS: The torsional stiffness of the bone-implant construct was low compared with nonfractured control femora (0.23 ± 0.1 Nmm/°versus 1.78 ± 0.15 Nmm/°, P<0.05). The cause of failure was a pullout of the distal screw. At 2 wk after stabilization, radiological analysis showed that most bones were partly bridged. At 5 wk, all bones showed radiological union. Accordingly, biomechanical analyses revealed a significantly higher torsional stiffness after 5 wk compared with that after 2 wk. Successful healing was indicated by a torsional stiffness of 90% of the contralateral control femora. Histological analyses showed new woven bone bridging the osteotomy without external callus formation and in absence of any cartilaginous tissue, indicating intramembranous healing.
CONCLUSION: With the model introduced herein we report, for the first time, successful metaphyseal bone repair in mice. The model may be used to obtain deeper insights into the molecular mechanisms of metaphyseal fracture healing.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22560849     DOI: 10.1016/j.jss.2012.04.007

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  6 in total

1.  Femoral strength after induced lesions in rats (Rattus norvegicus).

Authors:  Kathryn A Belill; Timothy L Settle; C Roselina Angel; Seon-Woo Kim; Stephen W Rothwell
Journal:  Comp Med       Date:  2014-06       Impact factor: 0.982

2.  A Minimally Invasive Model to Analyze Endochondral Fracture Healing in Mice Under Standardized Biomechanical Conditions.

Authors:  Tina Histing; Philipp Bremer; Mika F Rollmann; Steven Herath; Moritz Klein; Tim Pohlemann; Michael D Menger; Tobias Fritz
Journal:  J Vis Exp       Date:  2018-03-22       Impact factor: 1.355

3.  Experimental models for cancellous bone healing in the rat.

Authors:  Magnus Bernhardsson; Olof Sandberg; Per Aspenberg
Journal:  Acta Orthop       Date:  2015-08-27       Impact factor: 3.717

Review 4.  Inter-trabecular bone formation: a specific mechanism for healing of cancellous bone.

Authors:  Olof H Sandberg; Per Aspenberg
Journal:  Acta Orthop       Date:  2016-06-30       Impact factor: 3.717

5.  Effects of a Pasty Bone Cement Containing Brain-Derived Neurotrophic Factor-Functionalized Mesoporous Bioactive Glass Particles on Metaphyseal Healing in a New Murine Osteoporotic Fracture Model.

Authors:  Vivien Kauschke; Maike Schneider; Annika Jauch; Matthias Schumacher; Marian Kampschulte; Marcus Rohnke; Anja Henss; Coralie Bamberg; Katja Trinkaus; Michael Gelinsky; Christian Heiss; Katrin Susanne Lips
Journal:  Int J Mol Sci       Date:  2018-11-09       Impact factor: 5.923

6.  Establishment of a preclinical ovine screening model for the investigation of bone tissue engineering strategies in cancellous and cortical bone defects.

Authors:  Anne-Marie Pobloth; Kenneth A Johnson; Hanna Schell; Nicolai Kolarczik; Dag Wulsten; Georg N Duda; Katharina Schmidt-Bleek
Journal:  BMC Musculoskelet Disord       Date:  2016-03-01       Impact factor: 2.362

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.